APA (7th ed.) Citation

Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.

Chicago Style (17th ed.) Citation

Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, and SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.

MLA (9th ed.) Citation

Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.